Clinical Trial Update: Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 1/2 study of arsenic trioxide plus vitamin C in patients with recurrent or refractory multiple myeloma. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Ascorbic acid (Vitamin C)

Snippet

Sponsor: University of Miami | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED